Views: 0 Author: Site Editor Publish Time: 2023-10-21 Origin: Site
Win-Win cooperation, complementary advantages!
sysmex, a well-known multinational company, signed a strategic cooperation agreement with Jiangsu Zecen Biotech
On March 9, the strategic cooperation signing ceremony between Sysmex Medical Electronics (Shanghai) Co., Ltd. and Jiangsu Zecen Biotech Co., Ltd. was held in China Medical City. The two parties will further deepen the cooperation, and jointly promote the innovation and development of the in vitro diagnostic industry in our region through the integration of technology and resource advantages, and continue to add strength and empowerment to promote the high-quality development of the enlarged health industry in the High-tech Gaogang Dirstrict.
Ye Donghua, deputy mayor of Taizhou City, secretary of the Party Working Committee of the Pharmaceutical High-tech district, and secretary of the Gaogang District Committee, attended the signing ceremony and make a speech:
Both Sysmex and Zecen Biotech are well-known companies mainly engaged in in vitro diagnostic products. Sysmex, as a world-renowned multinational company, manufacturer of in vitro diagnostic products and provider of comprehensive clinical testing solutions, is a world leader in the fields of blood analysis, coagulation analysis, and urine sediment analysis; Zecen Biotech has been deeply engaged in chemiluminescence products for many years. It is an excellent in vitro diagnostic enterprise in Jiangsu Province. In 2014, it built a R&D and production base in the Biomedical Industrial Park in our district.
It is hoped that the two parties will take this signing as an opportunity to further promote mutual complementarity, common development, and win-win cooperation. At the same time, through the demonstration and leadership of the strategic cooperation between the two enterprises, more enterprises in the park will be encouraged to strengthen foreign exchanges, deepen friendship and cooperation, and broaden investment channels. Create more new situations of mutual benefit and win-win results.
At the signing ceremony,
Peng Zuohui,the global executive director and China regional CEO of Sysmex;
Liu Zhenshi, CEO of ZECEN Biotech
signed a strategic cooperation agreement on behalf of the two parties.
Ding Zhiqiang, Deputy Secretary of the Party Working Committee and Director of the Administrative Committee of the Pharmaceutical High-tech Zone, and Deputy Secretary of the CPC Gaogang District Committee and District President, presided over the signing ceremony.. Yang Yu, chairman of Sysmex China, as well as the head of the Biomedical Industrial Park and representatives of financial institutions in the region attended the signing ceremony.
Tissue peptide-specific antigen TPS Product Launch Event with complete success
Advancements in Chemiluminescence Immunoassay Systems: Magnetic Particle Separation Technology
Revolutionizing Healthcare with Immunoassay POCT Analyzers: Accuracy and Flexibility Combined
The Evolution of Biochemistry Analyzers: Enhancing Laboratory Efficiency and Reliability
Exhibition review | Highlights of Zecen Biotech & Medlab Asia 2024
The 2024 ZECEN Biotech Product Promotion Conference Was Successfully Held at CACLP
Innovation for Health,Quality for Life—— Zecen Biotech Germany MEDICA Exhibition Review